News & Media
Find recent and archived news, press releases, and stories here.
Neurocentria launches phase 2 trial in stage 2 AD patients focusing on cognition, mood, and sleep (NC010)
Jul 30, 2018
Neurocentria Launches Phase 2b Clinical Trial Testing the Efficacy of MMFS in Stage 3 and 4 Alzheimer’s Disease Patients (NC007b)
Apr 6, 2018
Neurocentria Announces Completion and Positive Top-Line Results of MMFS Trial in Adult ADHD
Mar 3, 2018
Neurocentria to Present New Data on MMFS in Mild-Moderate Alzheimer’s Disease at Alzheimer’s Association International Conference (AAIC) 2017
Jul 13, 2017
Neurocentria Publishes Article Demonstrating its Candidate Compound MMFS can Improve Brain Age by 9 Years in Older Adults with Mild Cognitive Impairment
Oct 28, 2015
Neurocentria Presents Results of Phase 2 Clinical Study of MMFS in Elderly with Mild Cognitive Impairment at Alzheimer’s Association International Conference (AAIC) 2015
Jul 13, 2015
Neurocentria Demonstrates that Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice
Sep 13, 2014